Noelia L. D'ELia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Noelia L. D'ELia has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Javier Sartuqui
Universidad Nacional del Sur, INQUISUR-CONICET
3 shared publications - Paula Verónica Messina
Instituto de Química del Sur, Universidad Nacional del Sur (UNS)-CONICET, Bahía Blanca 80000, Argentina
3 shared publications - Juan Manuel Ruso
University of Santiago de Compostela
2 shared publications A.N. Gravina
INQUISUR-CONICET, Universidad Nacional del Sur, Bahía Blanca, Argentina
1 shared publicationAna Della Rosa
1 shared publicationC. Mathieu
Department of Chemical Engineering, Ecole Polytechnique, Montréal, Canada
1 shared publication
Latest Publications
- Open Access
- 4 June 2026
- Published by Elsevier in SSRN Electronic Journal
Localized Ciprofloxacin Release by a Multifunctional Scaffold applied on Bone Regeneration: Assessment of Bioactivity, Biocompatibility, and Antibacterial Properties
Bone defects resulting from injuries or pathologies necessitate advanced filler materials that have evolved from passive integration to active roles in osseointegration and osteoinduction. This study presents the development of a multifunctional composite scaffold based on synthetic nano-hydroxyapatite (HA), sodium alginate (ALG), and calcium phosphate/carbonate cements (CPC) loaded with ciprofloxacin (CIP). The physicochemical behavior was assessed under simulated physiological conditions, revealing a pH-responsive performance: the scaffold maintains initial stability and high swelling at pH 7.4, while undergoing accelerated degradation at pH 4.2, mimicking the environment of active bone resorption. Optical microscopy with crossed polarizers confirmed the formation of birefringent three-dimensional structures (mesophases) that reinforce the matrix and provide a template for tissue organization. Bioactivity assays in simulated body fluid (SBF) demonstrated the progressive growth of biogenic hydroxyapatite, with extensive surface coverage achieved after 28 days, as validated by FE-SEM, XRD, and FT-IR analysis. Furthermore, the system ensures localized CIP release effective against the primary strains causing osteomyelitis while maintaining a hemolysis rate below 1%, confirming its excellent hemocompatibility. These findings establish this integral platform as a promising and safe antibacterial bone filler for localized tissue repair.
- 4 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessLocalized Ciprofloxacin Release by a Multifunctional Scaffold applied on Bone Regeneration: Assessment of Bioactivity, Biocompatibility, and Antibacterial Properties
Bone defects resulting from injuries or pathologies necessitate advanced filler materials that have evolved from passive integration to active roles in osseointegration and osteoinduction. This study presents the development of a multifunctional composite scaffold based on synthetic nano-hydroxyapatite (HA), sodium alginate (ALG), and calcium phosphate/carbonate cements (CPC) loaded with ciprofloxacin (CIP). The physicochemical behavior was assessed under simulated physiological conditions, revealing a pH-responsive performance: the scaffold maintains initial stability and high swelling at pH 7.4, while undergoing accelerated degradation at pH 4.2, mimicking the environment of active bone resorption. Optical microscopy with crossed polarizers confirmed the formation of birefringent three-dimensional structures (mesophases) that reinforce the matrix and provide a template for tissue organization. Bioactivity assays in simulated body fluid (SBF) demonstrated the progressive growth of biogenic hydroxyapatite, with extensive surface coverage achieved after 28 days, as validated by FE-SEM, XRD, and FT-IR analysis. Furthermore, the system ensures localized CIP release effective against the primary strains causing osteomyelitis while maintaining a hemolysis rate below 1%, confirming its excellent hemocompatibility. These findings establish this integral platform as a promising and safe antibacterial bone filler for localized tissue repair.
- Open Access
A mycelium biofactory: Novel biomaterial obtained by culturing Ganoderma sessile on a potential osteogenic substrate
Oral diseases represent a significant public health challenge, particularly periodontal and peri-implant diseases that result in considerable bone loss and diminished quality of life. To address these issues, tissue engineering techniques such as guided bone regeneration (GBR) utilize barrier membranes to promote bone defect healing. This study introduces a novel membrane employing Ganoderma sessile mycelium as a microstructural director for osteogenic biomaterials, achieving a mycelium-alginate-nanohydroxyapatite (My-ALG-HA) composite. This innovative strategy addresses the limitations of conventional biomaterials, including inadequate management of chewing forces, limited blood supply and microbial contamination. This approach uses the unique hierarchical structure and hydrophobic properties of Ganoderma mycelium alongside the biocompatibility and hydrophilicity of the ALG-HA system to improve the structural integrity and biological functionality. The mycelium colonizes the ALG-HA substrate, forming a porous trabecular bone-like network. Water contact angle assays indicated an anisotropic interaction behavior, and tensile testing confirmed the material ductility. Incorporating mycelium-derived molecules contributes to its hydrophobicity and resistance to degradation in simulated physiological conditions. Additionally, the My-ALG-HA biomaterial demonstrates human blood hemocompatibility and osteoblast-like cell (MC3T3-E1) cytocompatibility, highlighting its potential as an advanced solution for bone tissue regeneration in regenerative medicine.
Open AccessA mycelium biofactory: Novel biomaterial obtained by culturing Ganoderma sessile on a potential osteogenic substrate
Oral diseases represent a significant public health challenge, particularly periodontal and peri-implant diseases that result in considerable bone loss and diminished quality of life. To address these issues, tissue engineering techniques such as guided bone regeneration (GBR) utilize barrier membranes to promote bone defect healing. This study introduces a novel membrane employing Ganoderma sessile mycelium as a microstructural director for osteogenic biomaterials, achieving a mycelium-alginate-nanohydroxyapatite (My-ALG-HA) composite. This innovative strategy addresses the limitations of conventional biomaterials, including inadequate management of chewing forces, limited blood supply and microbial contamination. This approach uses the unique hierarchical structure and hydrophobic properties of Ganoderma mycelium alongside the biocompatibility and hydrophilicity of the ALG-HA system to improve the structural integrity and biological functionality. The mycelium colonizes the ALG-HA substrate, forming a porous trabecular bone-like network. Water contact angle assays indicated an anisotropic interaction behavior, and tensile testing confirmed the material ductility. Incorporating mycelium-derived molecules contributes to its hydrophobicity and resistance to degradation in simulated physiological conditions. Additionally, the My-ALG-HA biomaterial demonstrates human blood hemocompatibility and osteoblast-like cell (MC3T3-E1) cytocompatibility, highlighting its potential as an advanced solution for bone tissue regeneration in regenerative medicine.
- Open Access
- 1 July 2020
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 572, 408-420
Development and characterisation of bilayered periosteum-inspired composite membranes based on sodium alginate-hydroxyapatite nanoparticles
- 1 July 2020
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 572, 408-420
Open AccessDevelopment and characterisation of bilayered periosteum-inspired composite membranes based on sodium alginate-hydroxyapatite nanoparticles
- 1 May 2017
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 494, 345-354
Albumin-mediated deposition of bone-like apatite onto nano-sized surfaces: Effect of surface reactivity and interfacial hydration
- 1 May 2017
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 494, 345-354
Albumin-mediated deposition of bone-like apatite onto nano-sized surfaces: Effect of surface reactivity and interfacial hydration